Katharina Frey

861 total citations
22 papers, 645 citations indexed

About

Katharina Frey is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Katharina Frey has authored 22 papers receiving a total of 645 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Oncology. Recurrent topics in Katharina Frey's work include Monoclonal and Polyclonal Antibodies Research (7 papers), Cell Adhesion Molecules Research (4 papers) and Peptidase Inhibition and Analysis (3 papers). Katharina Frey is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), Cell Adhesion Molecules Research (4 papers) and Peptidase Inhibition and Analysis (3 papers). Katharina Frey collaborates with scholars based in Germany, Switzerland and United Kingdom. Katharina Frey's co-authors include Dario Neri, Kathrin Schwager, Alessandra Villa, Christoph Schliemann, Roland E. Kontermann, Dafne Müller, Nadine Pasche, Wolfram Klapper, Christoph E. Dumelin and Sabrina Trüssel and has published in prestigious journals such as PLoS ONE, The Journal of Urology and Science Translational Medicine.

In The Last Decade

Katharina Frey

21 papers receiving 624 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katharina Frey Germany 14 302 294 237 235 64 22 645
Yogindra Vedvyas United States 14 488 1.6× 95 0.3× 180 0.8× 205 0.9× 28 0.4× 25 692
Manuela Silginer Switzerland 16 344 1.1× 74 0.3× 415 1.8× 289 1.2× 56 0.9× 31 1.0k
Rona Ortenberg Israel 15 254 0.8× 149 0.5× 375 1.6× 218 0.9× 74 1.2× 23 700
Patrizia Alessi Italy 16 131 0.4× 126 0.4× 332 1.4× 236 1.0× 66 1.0× 16 664
Maïté Verreault France 16 244 0.8× 62 0.2× 392 1.7× 63 0.3× 45 0.7× 38 873
Shenghua Wen United States 11 202 0.7× 108 0.4× 396 1.7× 71 0.3× 22 0.3× 21 616
Noriaki Sugawa Japan 8 470 1.6× 187 0.6× 544 2.3× 96 0.4× 31 0.5× 13 1.1k
Maya Zigler United States 17 300 1.0× 61 0.2× 565 2.4× 273 1.2× 109 1.7× 23 961
Ralf Lutterbuese Germany 10 615 2.0× 523 1.8× 283 1.2× 393 1.7× 12 0.2× 15 876
Zev A. Binder United States 22 475 1.6× 173 0.6× 476 2.0× 237 1.0× 14 0.2× 69 1.2k

Countries citing papers authored by Katharina Frey

Since Specialization
Citations

This map shows the geographic impact of Katharina Frey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katharina Frey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katharina Frey more than expected).

Fields of papers citing papers by Katharina Frey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katharina Frey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katharina Frey. The network helps show where Katharina Frey may publish in the future.

Co-authorship network of co-authors of Katharina Frey

This figure shows the co-authorship network connecting the top 25 collaborators of Katharina Frey. A scholar is included among the top collaborators of Katharina Frey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katharina Frey. Katharina Frey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frey, Katharina, et al.. (2022). Laser Metal Deposition of AlSi10Mg with high build rates. Procedia CIRP. 111. 210–213. 5 indexed citations
2.
Fankhauser, Laura, Patrick N. Harter, Colin D.H. Ratcliffe, et al.. (2021). BSCI-11. Targeting PI3K/Akt/mTOR pathway to prevent melanoma brain metastasis. Neuro-Oncology Advances. 3(Supplement_3). iii3–iii3. 3 indexed citations
3.
Fankhauser, Laura, Patrick N. Harter, Colin D.H. Ratcliffe, et al.. (2021). The PI3K/Akt/mTOR pathway as a preventive target in melanoma brain metastasis. Neuro-Oncology. 24(2). 213–225. 48 indexed citations
4.
Berghoff, Anna S., Matthia A. Karreman, Katharina Frey, et al.. (2020). Nintedanib and a bi-specific anti-VEGF/Ang2 nanobody selectively prevent brain metastases of lung adenocarcinoma cells. Clinical & Experimental Metastasis. 37(6). 637–648. 18 indexed citations
5.
Setzer, Matthias, et al.. (2019). Upright MRI after decompression of spinal stenosis and concurrent spondylolisthesis. Neurosurgical FOCUS. 46(5). E14–E14.
6.
Frey, Katharina, et al.. (2019). Provision of Fast Frequency Response by SVC PLUS Frequency Stabilizer. 53 (6 pp.)–53 (6 pp.). 7 indexed citations
7.
Frey, Katharina, et al.. (2018). Inertia in the System and First Swing Frequency-Description and Mitigation Possibilities. 1–9. 3 indexed citations
8.
Frey, Katharina, et al.. (2016). Automated operation of parallel VSC HVDC links within an interconnected AC network. tb 536. 1–5. 7 indexed citations
9.
Frey, Katharina, et al.. (2016). Dynamic curtailment method for renewable energy sources in distribution grid planning. 1–5. 13 indexed citations
10.
Gutbrodt, Katrin L., Christoph Schliemann, Leonardo Giovannoni, et al.. (2013). Antibody-Based Delivery of Interleukin-2 to Neovasculature Has Potent Activity Against Acute Myeloid Leukemia. Science Translational Medicine. 5(201). 201ra118–201ra118. 93 indexed citations
11.
Frey, Katharina, et al.. (2012). Combination of a Bispecific Antibody and Costimulatory Antibody-Ligand Fusion Proteins for Targeted Cancer Immunotherapy. Journal of Immunotherapy. 35(5). 418–429. 38 indexed citations
12.
Frey, Katharina, Ramona Schmid, Zacharias Kohl, et al.. (2011). Leucine-Rich Repeat Kinase 2 Modulates Retinoic Acid-Induced Neuronal Differentiation of Murine Embryonic Stem Cells. PLoS ONE. 6(6). e20820–e20820. 17 indexed citations
13.
Frey, Katharina, Kathrin Schwager, Benedetta Belloni, et al.. (2011). Different patterns of fibronectin and tenascin-C splice variants expression in primary and metastatic melanoma lesions. Experimental Dermatology. 20(8). 685–688. 51 indexed citations
14.
Pasche, Nadine, Janine Woytschak, Sarah Wulhfard, et al.. (2011). Cloning and characterization of novel tumor-targeting immunocytokines based on murine IL7. Journal of Biotechnology. 154(1). 84–92. 54 indexed citations
15.
Pasche, Nadine, Katharina Frey, & Dario Neri. (2011). The targeted delivery of IL17 to the mouse tumor neo-vasculature enhances angiogenesis but does not reduce tumor growth rate. Angiogenesis. 15(1). 165–169. 21 indexed citations
16.
Frey, Katharina, et al.. (2011). Antibody-based targeting of interferon-alpha to the tumor neovasculature: a critical evaluation. Integrative Biology. 3(4). 468–478. 57 indexed citations
17.
Fiechter, Michael, Katharina Frey, Tim Fugmann, Philipp A. Kaufmann, & Dario Neri. (2010). Comparative in vivo analysis of the atherosclerotic plaque targeting properties of eight human monoclonal antibodies. Atherosclerosis. 214(2). 325–330. 22 indexed citations
18.
Frey, Katharina, et al.. (2010). Tumour-targeting properties of antibodies specific to MMP-1A, MMP-2 and MMP-3. European Journal of Nuclear Medicine and Molecular Imaging. 37(8). 1559–1565. 17 indexed citations
19.
Trüssel, Sabrina, Christoph E. Dumelin, Katharina Frey, et al.. (2009). New Strategy for the Extension of the Serum Half-Life of Antibody Fragments. Bioconjugate Chemistry. 20(12). 2286–2292. 72 indexed citations
20.
Müller, Dafne, Katharina Frey, & Roland E. Kontermann. (2008). A Novel Antibody–4-1BBL Fusion Protein for Targeted Costimulation in Cancer Immunotherapy. Journal of Immunotherapy. 31(8). 714–722. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yogindra Vedvyas Breakdown of academic impact, for papers by Manuela Silginer Breakdown of academic impact, for papers by Rona Ortenberg Breakdown of academic impact, for papers by Patrizia Alessi Breakdown of academic impact, for papers by Maïté Verreault Breakdown of academic impact, for papers by Shenghua Wen Breakdown of academic impact, for papers by Noriaki Sugawa Breakdown of academic impact, for papers by Maya Zigler Breakdown of academic impact, for papers by Ralf Lutterbuese Breakdown of academic impact, for papers by Zev A. Binder
Rankless by CCL
2026